reports
- GlobalData Healthcare Department
SciClone Pharmaceuticals Inc (SCLN) - Financial and Strategic SWOT Ana...
SciClone Pharmaceuticals Inc (SCLN) - Financial and Strategic SWOT Analysis Review Summary SciClone Pharmaceuticals Inc (SciClone) is a pharmaceutical company that develops and commercializes novel therapies for varied therapeutic areas such as oncology, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin), an immunostimulatory agent is used for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), sepsis, cancer and as an immune sy...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.